Women with dense breasts or a first-degree relative with breast cancer are twice as likely as average-risk women to develop breast cancer in their 40s[1] and these women would benefit from beginning mammography screening at age 40[2], according to the... Continue Reading

Patients age 50-70 with previously untreated acute myeloid leukemia (AML) who are treated with Mylotarg® (gemtuzumab ozogamicin) plus standard chemotherapy appear to live longer than those who are treated with standard chemotherapy alone, according to... Continue Reading

Cancer-related fatigue (CRF) is common after treatment for early stage breast cancer, but new results indicate that the phenomenon fades over time, according to a study published in the Journal of Clinical Oncology. Breast cancer is the most commonly... Continue Reading

Chemotherapy plus radiation reduces the risk of recurrence in muscle-invasive bladder cancer patients by nearly 50% compared to radiation alone, according to the results of a study published in the New England Journal of Medicine.[1] Bladder cancer is... Continue Reading

Patients with early stage kidney cancer who had only the tumor removed experienced better survival rates than those who had the entire kidney removed, according to the results of a study published in the Journal of the American Medical Association.[1] Nearly... Continue Reading

In an analysis of three different types of radiation therapy used to treat localized prostate cancer, intensity-modulated radiation therapy (IMRT) was associated with fewer gastrointestinal side effects and fewer hip fractures, but more erectile dysfunction... Continue Reading

The addition of Avastin (bevacizumab) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) did not improve survival rates in patients over age 65 with advanced NSCLC, according to the results of a study published in the Journal... Continue Reading

Minimally-invasive radical prostatectomy (MIRP) proves safer than traditional open surgery—resulting in fewer post-surgical complications, fewer blood transfusions, and shorter hospital stays, according to the results of a study published in European... Continue Reading

Tivozanib (AV-951) was well tolerated and improved median progression-free survival (PFS) in some patients with advanced renal cell carcinoma (RCC), according to the results of a phase II study published in the Journal of Clinical Oncology. More than... Continue Reading

A subset of young patients with acute lymphoblastic leukemia (ALL) who fail to achieve remission after the initial weeks of intense chemotherapy known as induction therapy appear to have better outcomes with additional chemotherapy rather than bone marrow... Continue Reading

Healthy women at average risk for ovarian cancer do not need to get screened for the disease, according to the U.S. Preventive Services Task Force (USPSTF). After a recent review of the data, the government panel has renewed its 2004 recommendation against... Continue Reading

People who were underwent frequent dental x-rays in the past—when radiation exposure was higher than it is today—have an increased risk of developing intracranial meningioma, according to the results of a study published early online in Cancer.[1] Meningiomas... Continue Reading